Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) SHZ
1.58
+0.02(+1.28%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 14.09B |
| Enterprise Value | 11.35B |
| P/E Ratio | -12.15 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 0.16 |
| Price/Book Ratio | 0.38 |
| Enterprise/Revenue | 0.1 |
| Enterprise/EBITDA | -5.02 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | 0.02 |
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0.03 |
Income Statement
| Revenue | 49.7B |
| Revenue/Share | 9.91 |
| Gross Profit | 39.87B |
| EBITDA | -999.25M |
| Net Income | -651.76M |
| Diluted EPS | -0.13 |
Balance Sheet
| Total Cash | 10.57B |
| Total Cash/Share | 5.97 |
| Total Debt | 17.56B |
| Total Debt/Equity | 1.23 |
| Current Ratio | 2.07 |
| Book Value Per Share | 6.71 |
Price History
| 52-Week Change | -53.67 |
| 52-Week High | 5.42 |
| 52-Week Low | 1.35 |
| Moving Average 50 Days | 2.23 |
| Moving Average 200 Days | 3.43 |
Statistics
| Average Volume | 52.4M |
| Shares Outstanding | 4.9B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.83 |
| Last Split Factor | 37:20 |
| Last Split Date | April 12, 2010 |
